ClinicalTrials.Veeva

Menu

Comparing Surgical Management Methods of Atrial Fibrillation

C

Corewell Health West

Status

Invitation-only

Conditions

Atrial Fibrillation

Treatments

Procedure: Atrial Fibrillation Ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT07100483
2025-1012

Details and patient eligibility

About

Compare the efficacy of the left atrial Cox-Maze IV lesion set versus the Tampa 2 lesion set versus the EnCompass ablation alone, in the surgical treatment of atrial fibrillation at one year post-operatively.

Full description

This is a single center prospective, randomized trial to compare the outcomes, specifically the freedom from atrial fibrillation at one year, and possibly up to five years, of three different approaches to the cardiac surgical management of atrial fibrillation.

Several strategies to accomplish surgical ablation are acceptable and have been shown retrospectively to be successful. The Cox-Maze bi-atrial, left and right atrial lesions, ablation (whether III or IV) remains the gold standard by which all surgical ablations are compared. Further refinement in ablation technology and research has further suggested there is no difference between a left atrial ablation alone or bi-atrial ablation lesion set. For left atrial ablation alone, existent therapeutic options, which all meet equivalent standard of care, include a left atrial Cox-Maze IV , a Tampa 2 lesion set or utilizing a "box lesion" alone. Currently, there are no randomized, clinical trials demonstrating better efficacy (freedom from atrial fibrillation post-operatively) of one ablation strategy over another in patients undergoing cardiac surgery.

The rationale for the study is to demonstrate whether one ablation technique is more efficacious in the surgical treatment of AF. Should one technique prove superior it may clarify the question of which ablation strategy to utilize and encourage surgeons to implement a consistent approach to surgical ablation.

To our knowledge this study would be the first prospective, randomized trial in the United States comparing surgical lesion sets in the concomitant management of atrial fibrillation.

Enrollment

220 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients with a history of preoperative atrial fibrillation, either paroxysmal or persistent, requiring concomitant surgical ablation who are scheduled to undergo cardiac surgical procedure(s) to be performed on cardiopulmonary bypass
  • Utilizing sternotomy approach requiring cardiopulmonary bypass
  • Male or Female subjects between age 18 to 85 years of age

Exclusion criteria

  • LVEF < 25%
  • LAVI > 59ml/m②
  • Presence of Pacemaker/AICD
  • History of VT/VF, WPW
  • Re-operative cardiac surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

220 participants in 3 patient groups

Cox-Maze IV
Active Comparator group
Description:
Lesion created around the pulmonary vein ostia (openings). Lesion to posterior (back) of the mitral annulus (fibrous ring around the mitral valve leaflets). Lesion from the 'box' to the left atrial appendage. There is also one lesion on the outside of the heart at the coronary sinus (main vein draining the heart)- not shown in this picture due to being on the outside of the heart. The Left Atrial Appendage will also be either excluded or removed.
Treatment:
Procedure: Atrial Fibrillation Ablation
Tampa 2
Active Comparator group
Description:
Lesion created around the pulmonary vein ostia (openings). Lesion from the 'box' to the left atrial appendage Lesion from the left atrial appendage to the anterior (front) of the mitral annulus (fibrous ring around the mitral valve leaflets). This lesion is done through the left atrial appendage. The Left Atrial Appendage will also be either excluded or removed.
Treatment:
Procedure: Atrial Fibrillation Ablation
Encompass Alone
Active Comparator group
Description:
Lesion created around the pulmonary vein ostia (openings). The Left Atrial Appendage will also be either excluded or removed.
Treatment:
Procedure: Atrial Fibrillation Ablation

Trial contacts and locations

1

Loading...

Central trial contact

Denise Wittenbach, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems